Genovis has signed a Letter of Intent for the acquisition of all shares in the privately held company QED Bioscience Inc. (QED), based in San Diego, California. The acquisition is expected to be completed during the first quarter of 2020 and is subject to the customary terms and conditions for possession.Genovis intends to make a […]
Molecular Biology Systems and Velocidy Bio sign distribution agreement. NEXTGENPCR, the ultrafast PCR system, is now available in the United States and Canada. Goes, Netherlands — Molecular Biology Systems (MBS), the developer of NEXTGENPCR, is pleased to announce their newest distributor, Velocidy Bio. Velocidy Bio becomes the exclusive distributor of NEXTGENPCR instruments, accessories and consumables […]
New product enables high DNA library complexity from low-quality samples at industry-leading conversion rates CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, has launched the xGen Prism DNA Library Prep Kit, designed to produce high-quality Next Generation Sequencing (NGS) data from precious but challenging samples, assisting in the early detection of cancer […]
MONTREAL — Bioauxilium Research Inc., a Canadian biotech specialized in the development and manufacturing of world-class time-resolved Förster resonance energy transfer (TR‑FRET) assay kits, announced today the launch of its proprietary no-wash THUNDER™ TR‑FRET cellular platform with the introduction of 68 new cell signaling assay kits. These top-quality, fully validated yet affordable cell-based kinase kits were […]
Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges, has announced up to EUR 50M financing from Gamma Biosciences, a new investment platform supported by leading global investment firm KKR, that is focused on next-generation bioprocessing technologies for the production of advanced biologic therapies including gene- […]
LIVERMORE, Calif.– S2 Genomics, a manufacturer and provider of automated tissue sample preparation systems, and the RIKEN Center for Integrative Medical Sciences (IMS), a leading genomics research institute, today announced that RIKEN IMS has joined the S2 Genomics Early Technology Access Program to evaluate and further develop single cell sequencing applications on the S2 Genomics […]
THOROLD, ON – Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein stabilization and purification, today announced that they are offering a number of products to the scientific and medical community to support the study of the 2019 Novel Coronavirus (COVID-19, formerly 2019-nCoV) […]
– Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs – Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Mass. — Covaris, Inc. today announced the release of two new kits for viral RNA extraction from nasal or throat […]
Kit isolates high molecular weight single-stranded DNA efficiently, without bias FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a novel DNA isolation product. Shoreline Rapid Prep is a fast and easy-to-use kit designed for efficient and unbiased isolation of high molecular weight […]
Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling researchers to quickly print DNA required to discover vaccines and therapeutics. SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, announces a focused […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
